ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

The 2012 Annual Meeting of Stockholders of Neurocrine Biosciences, Inc. (the "Annual Meeting") was held on May 23, 2012. As of the close of business on April 2, 2012, the record date for the Annual Meeting, there were 66,306,302 shares of common stock entitled to vote, of which there were 61,730,907 shares present at the Annual Meeting in person or by proxy. At the Annual Meeting, stockholders voted on three matters: (i) the election of two Class I Directors for a term of three years expiring at the 2015 Annual Meeting of Stockholders,
(ii) an advisory vote on the compensation paid to the named executive officers, and (iii) the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2012. The voting results were as follows:

• Election of two Class I Directors for a term of three years expiring at the 2015 Annual Meeting of Stockholders

W. Thomas Mitchell For 26,686,552 Withheld 21,458,365 Joseph A. Mollica, Ph.D. For 26,676,240 Withheld 21,468,677

The two nominees for Class I Director were elected. Our Class II Directors, Corinne H. Nevinny, Richard F. Pops, and Stephen A. Sherwin, M.D., continue in office until our 2013 Annual Meeting of Stockholders. Our Class III Directors, Kevin C. Gorman, Ph.D., Gary A. Lyons, and William H. Rastetter, Ph.D., continue in office until our 2014 Annual Meeting of Stockholders.

There were 13,585,990 broker non-votes related to each of the two director nominees for election.

• An advisory vote on the compensation paid to the named executive officers

Shares Voted: For 45,616,556 Against 1,646,957 Abstain 881,404

There were 13,585,990 broker non-votes for this proposal.

The compensation paid to the Company's named executive officers was approved on an advisory basis.

• Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2012

Shares Voted: For 60,319,479 Against 483,339 Abstain 928,089

The appointment of Ernst & Young LLP was ratified.

---